[
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors",
    "summary": "Vertex Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=d9810157585d2325e788d56f34a3d92061c91a95d814638e66932bb10a4cf82a",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747845420,
      "headline": "Vertex Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors",
      "id": 134636042,
      "image": "",
      "related": "VRTX",
      "source": "MarketWatch",
      "summary": "Vertex Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=d9810157585d2325e788d56f34a3d92061c91a95d814638e66932bb10a4cf82a"
    }
  },
  {
    "ts": null,
    "headline": "Harding Loevner Global Equity Q1 2025 Report",
    "summary": "The Harding Loevner Global Equity composite fell by 2.0% (gross) in Q1 2025, worse than the 1.2% drop in the MSCI ACWI Index. Click here to read the full commentary.",
    "url": "https://finnhub.io/api/news?id=98a5eac5e427a7b124c5429237c370dbe0e534916d53d5d16a6d14779f573ac0",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747818900,
      "headline": "Harding Loevner Global Equity Q1 2025 Report",
      "id": 134625372,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1303046106/image_1303046106.jpg?io=getty-c-w1536",
      "related": "VRTX",
      "source": "SeekingAlpha",
      "summary": "The Harding Loevner Global Equity composite fell by 2.0% (gross) in Q1 2025, worse than the 1.2% drop in the MSCI ACWI Index. Click here to read the full commentary. ",
      "url": "https://finnhub.io/api/news?id=98a5eac5e427a7b124c5429237c370dbe0e534916d53d5d16a6d14779f573ac0"
    }
  },
  {
    "ts": null,
    "headline": "Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030",
    "summary": "Vertex Pharmaceuticals should have big winners with pain drug Journavx and two promising pipeline candidates.  Summit Therapeutics is poised for major success with its cancer immunotherapy, ivonescimab.  People need healthcare products and services regardless of what's happening with the economy.",
    "url": "https://finnhub.io/api/news?id=d9311d57a81efc5b50ac3a0ff8729230bdde472d97898cdf331e0a94bbd95cb6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747817280,
      "headline": "Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030",
      "id": 134628581,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Vertex Pharmaceuticals should have big winners with pain drug Journavx and two promising pipeline candidates.  Summit Therapeutics is poised for major success with its cancer immunotherapy, ivonescimab.  People need healthcare products and services regardless of what's happening with the economy.",
      "url": "https://finnhub.io/api/news?id=d9311d57a81efc5b50ac3a0ff8729230bdde472d97898cdf331e0a94bbd95cb6"
    }
  }
]